Pharmafile Logo
Pharmafocus logo
Advanced Search

atrial fibrillation

Showing 15 posts of 20 posts found.

Acesion Pharma raises €45m series B funding

September 26, 2023
Business Services Acesion Pharma, Cardiology, atrial fibrillation, series B financing

Acesion Pharma has announced that it has closed an oversubscribed €45m series B financing round. This financing was co-led by …

News
fdaoutsideweb

Correvio’s atrial fibrillation drug voted down by FDA committee over safety concerns

December 11, 2019
Research and Development, Sales and Marketing Correvio Pharma, FDA, atrial fibrillation, pharma

It has emerged that Correvio Pharma’s anti-arrhythmic therapy Brinavess was shot down by the FDA’s Cardiovascular and Renal Drugs Advisory …

News

AI accurately detects subtle signs of atrial fibrillation even in normal tests

August 2, 2019
Medical Communications AF, AI, ECG, atrial fibrillation, electrcardiogram, pharma

A new study from the Mayo Clinic shows that artificial intelligence (AI) can detect signs of atrial fibrillation (AF) in …

News
heart-2372134_640

Two biomarkers can aid in atrial fibrillation screening, researchers find

January 8, 2019
Manufacturing and Production, Research and Development University of Birmingham, atrial fibrillation, biomarkers, pharma

A team of researchers at the University of Birmingham has identified a pair of biomarkers which it says could aid …

News
tony_green_edit

Living with atrial fibrillation

April 23, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing KardiaMobile, Tony Green, atrial fibrillation, patient experience

Tony Green discusses the difficulty in pinning down his diagnosis of the irregular heart rhythm condition, until his use of …

Feature
pharmafocus_april_2018_cover

The April 2018 issue of Pharmafocus is now live!

March 27, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Janssen, Martin Shkreli, Right to try, atrial fibrillation, falsified medicines directive, oncology, opioids, pharma

As we finally pass into Spring after what still feels like a particularly stubborn Winter, we are pleased to announce …

News
kardia_mobile_give_credit_to_alivecor

Smartphone ECG device KardiaMobile rolled out to NHS to combat atrial fibrillation

February 14, 2018
Research and Development KardiaMobile, NHS, atrial fibrillation, pharma

AliveCor has announced that it has begun the rollout of its KardiaMobile technology to the NHS via the UK’s Academic …

News
shutterstock_95714119

1 in 6 US patients are given wrong dose of blood-thinners, study suggests

June 7, 2017
Research and Development Mayo Clinic, atrial fibrillation, blood thinner, blood-thinner

New research data from the Mayo Clinic has suggested that as much as one in six patients suffering from atrial …

News
Xarelto

Bayer backs safety of Xarelto after real-world data study

September 2, 2015
Research and Development Bayer, ESC, European Society of Cardiology, Xarelto, anticoagulants, atrial fibrillation, real-word evidence, rivaroxaban

Around 96 in every 100 people treated with Bayer’s anticoagulant Xarelto do not experience any major bleeding, related side effects …

News
Daiichi Sankyo

Daiichi scores another NICE nod for Lixiana

August 12, 2015
Sales and Marketing Daichii Sankyo, Daiichi, Lixiana, atrial fibrillation, edoxaban

NICE has recommended in draft guidance the anti-blood clotting drug Daiichi Sankyo’s Lixiana for preventing stroke and blood clots in …

News
Daiichi image

Daiichi Sankyo launches clotting drug Lixiana in UK

July 10, 2015
Medical Communications, Sales and Marketing Daiichi Sankyo, Lixiana, NOAC, VTE, anticoagulant, atrial fibrillation, blood clots, edoxaban, novel anticoagulant, strokes, warfarin

Daiichi Sankyo’s Lixiana has become the latest pharma offering in the class of newer oral anticoagulants in the UK.Lixiana (edoxaban) …

News
Daiichi image

Daiichi-Sankyo blood drug gets FDA nod

January 12, 2015
Sales and Marketing BMS, Daiichi Sankyo, Daiichi-Sankyo, FDA, Pfizer, Pradaxa, atrial fibrillation, blood, savaysa

The US Food and Drug Administration has shown Daiichi-Sankyo’s anti-clotting drug Savaysa the green light to reduce the risk of …

News
Merck image

Merck ends development on atrial fibrillation pill

March 20, 2012
Research and Development, Sales and Marketing Cardiome, Merck, atrial fibrillation

Merck will no longer help its partner Cardiome develop an oral formulation of the atrial fibrillation drug vernakalant. The pill …

News
Pradaxa image

NICE recommends Pradaxa for stroke prevention

March 15, 2012
Sales and Marketing Boehringer Ingelheim, NICE, Pradaxa, atrial fibrillation

NICE has given a limited recommendation to Boehringer Ingelheim’s blood thinner Pradaxa. The watchdog said in final guidance that Pradaxa …

News

NICE set to reject Xarelto in AF

January 10, 2012
Sales and Marketing AF, NICE, Pradaxa, Xarelto, atrial fibrillation

NICE says it needs more data on Bayer’s Xarelto in order to recommend it for people with atrial fibrillation. The …

News

Latest content

Mirum Pharmaceuticals publishes phase 3 MARCH maralixibat data in The Lancet

May 8, 2024

Circular Genomics reveals study results into predicting patient response to SSRI antidepressant treatment

May 8, 2024

Gossamer Bio and Chiesi Group enter into international collaboration to commercialise Seralutinib

May 7, 2024

Broken String Biosciences and the Francis Crick Institute collaborate on ALS research

May 7, 2024

AbbVie invests €150m in new R&D facility in Germany

May 3, 2024